OQROGet OQRO Pro
Insider trade

Neurocrine Biosciences (NBIX)Director sold ~$269K

Kevin Charles Gorman, Director at Neurocrine Biosciences, sold ~$269K of Neurocrine Biosciences shares.

~$269K
Approx. value · 2,274 sh @ $118.37
519K
Holds after · shares reported
Traded
Feb 10, 2025
Filed
Feb 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 17, 2024InsiderOfficer sold ~$147K of NBIX shares in the open market
  2. Dec 31, 2024InsiderOfficer sold ~$38K of NBIX shares in the open market
  3. Jan 15, 2025Insider · 1 personInsiders: 2 sales (~$9.2M)
  4. Jan 27, 2025InsiderDirector sold ~$21.8M of NBIX shares in the open market
  5. Jan 31, 2025Insider · 10 peopleInsiders: 11 sales (~$2.0M)
  6. Feb 3, 2025InsiderOfficer sold ~$93K of NBIX shares in the open market
  7. Feb 10, 2025 · this disclosureInsiderDirector sold ~$269K of NBIX shares in the open market

What came next

  1. Feb 10, 2025Insider · 7 peopleInsiders: 7 sales (~$737K)
  2. Feb 13, 2025Insider · 11 peopleInsiders: 21 sales (~$4.5M)
  3. Feb 14, 2025InsiderOfficer sold ~$58K of NBIX shares in the open market
  4. May 5, 2025InsiderDirector sold ~$3.31M of NBIX shares in the open market
  5. May 27, 2025InsiderDirector sold ~$1.16M of NBIX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neurocrine Biosciences

For Neurocrine Biosciences, OQRO holds 13 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NBIX page.

Other recent filings by Kevin Charles Gorman, Director

The full history of Kevin Charles Gorman, Director is on the profile page.

How this filing works

Other disclosures at Neurocrine Biosciences

Everything OQRO holds on this company is on its NBIX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data